This is the authors' abstract. We don't add key points for this paper.
Reduction potential and lipophilicity of the copper(II) bis(thiosemicarbazone) complexes can be independently controlled by alkylation in the diketone backbone and the N-termini of the ligand, allowing optimisation of radiopharmaceuticals strongly selective for hypoxic tissues.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Dearling et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: